Y-Intercept (HK)’s Pulmonx LUNG Stock Holding History

Y-Intercept (HK)’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-24,764	Closed	-$157K	–	1590
2024 Q2	$157K	Buy	24,764 +7,798	+46%	+$60K	0.01%	1208
2024 Q1	$157K	Buy	+16,966	New	+$199K	0.01%	1201

Other funds holding LUNG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Y-Intercept (HK)'s LUNG Position: Q3 2024 in Review

Y-Intercept (HK) sold out of Pulmonx (LUNG) in Q3 2024, closing a stake of 24,764 shares — an estimated $157K sold.

Y-Intercept (HK) first reported a position in LUNG in Q1 2024 and held it in 2 quarters. The position peaked at $157K in Q1 2024. 113 funds tracked by Wall St. Rank hold LUNG as of Q3 2024.

Y-Intercept (HK) reported no remaining Pulmonx position as of Q3 2024 after selling out during the quarter.
Y-Intercept (HK) sold 24,764 Pulmonx shares in Q3 2024, an estimated $157K.
Y-Intercept (HK) first reported a position in Pulmonx in Q1 2024 and held it in 2 quarters.
Y-Intercept (HK)'s Pulmonx position peaked at $157K in Q1 2024.
113 funds tracked by Wall St. Rank held Pulmonx as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.